Beate S Müller
Dados Biográficos
| ID | 6779866 |
|---|---|
| NOME | Beate S Müller |
| PRENOMES | Beate S |
| SOBRENOME | Müller |
| ASSINATURA | MULLER B S |
| AFILIAÇÕES | University of Cologne |
| ORCID | 0000-0002-6745-1047 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Making data accompany the patient and prescription to improve pharmaco-therapy safety. Lessons from three aligned German initiatives
Data play key role play in prescribing and drug therapy: data on patient health and co-morbidity status, on prescribed medication, on over-the-counter (OTC) drugs and other self-medication etc. In Germany, data are not yet flowing with the patients (or the prescriptions) on their way from GP practice into pharmacy, from hospital discharge to the GP or into the nursing home or across any sectoral boundaries characterising complex care trajectories…
Patient safety and climate change
Our study highlights patient safety as a public health concern in the era of climate change. The German public appears to view climate change as harmful to patient safety. Our findings also show that it is necessary to carry out diagnoses focused on demographic and socioeconomic factors to determine which aspects should be strengthened through programs aimed at reducing patient safety risks associated with climate change
Patient Safety and the Covid-19 Pandemic in Germany
The coronavirus (COVID-19) has presented Germany with major challenges and has led to concerns about patient safety. We conducted an observational, population-based, nationwide, repeated cross-sectional survey on patient safety in Germany in 2019, 2020, and 2021. Each of the three samples consisted of 1000 randomly recruited adults. Self-reported data via computer-assisted telephone interviews were taken from TK Monitor of Patient Safety. Percept…
Sem obras proeminentes nesta página.
Patient Safety and the Covid-19 Pandemic in Germany
The coronavirus (COVID-19) has presented Germany with major challenges and has led to concerns about patient safety. We conducted an observational, population-based, nationwide, repeated cross-sectional survey on patient safety in Germany in 2019, 2020, and 2021. Each of the three samples consisted of 1000 randomly recruited adults. Self-reported data via computer-assisted telephone interviews were taken from TK Monitor of Patient Safety. Percept…
Patient safety and climate change
Our study highlights patient safety as a public health concern in the era of climate change. The German public appears to view climate change as harmful to patient safety. Our findings also show that it is necessary to carry out diagnoses focused on demographic and socioeconomic factors to determine which aspects should be strengthened through programs aimed at reducing patient safety risks associated with climate change
Making data accompany the patient and prescription to improve pharmaco-therapy safety. Lessons from three aligned German initiatives
Data play key role play in prescribing and drug therapy: data on patient health and co-morbidity status, on prescribed medication, on over-the-counter (OTC) drugs and other self-medication etc. In Germany, data are not yet flowing with the patients (or the prescriptions) on their way from GP practice into pharmacy, from hospital discharge to the GP or into the nursing home or across any sectoral boundaries characterising complex care trajectories…
Health care (3 obras) · Medicine (3 obras) · Cross-sectional study (2 obras) · Environmental health (2 obras) · Nursing (2 obras) · Patient safety (2 obras) · Population (2 obras) · Biostatistics (1 obras) · Climate change (1 obras) · Climate Change and Health Impacts (1 obras)